161 related articles for article (PubMed ID: 37401225)
1. Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Ali M; Kerio AA; Khattak TA; Hussain M; Khan MA; Abbas Y
J Coll Physicians Surg Pak; 2023 Jul; 33(7):804-808. PubMed ID: 37401225
[TBL] [Abstract][Full Text] [Related]
2. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of cryotherapy against oral mucositis among allogeneic hematopoietic stem cell transplant recipients using melphalan-based conditioning.
Oku S; Futatsuki T; Imamura Y; Hikita H; Inada A; Mizutani S; Mori Y; Kashiwazaki H
Support Care Cancer; 2023 Aug; 31(9):521. PubMed ID: 37581845
[TBL] [Abstract][Full Text] [Related]
4. CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation.
Anand A; Anandi P; Jain NA; Lu K; Dunavin N; Hourigan CS; Le RQ; Chokshi PD; Ito S; Stroncek DF; Sabatino M; Barrett AJ; Battiwalla M
Support Care Cancer; 2016 Feb; 24(2):815-822. PubMed ID: 26190358
[TBL] [Abstract][Full Text] [Related]
5. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
Chen J; Seabrook J; Fulford A; Rajakumar I
J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
[TBL] [Abstract][Full Text] [Related]
6. The incidence of severe oral mucositis in patients undergoing different conditioning regimens in haematopoietic stem cell transplantation.
Nakagaki M; Kennedy GA; Gavin NC; Clavarino A; Whitfield K
Support Care Cancer; 2022 Nov; 30(11):9141-9149. PubMed ID: 36008731
[TBL] [Abstract][Full Text] [Related]
7. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
[TBL] [Abstract][Full Text] [Related]
8. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
Blijlevens N; Schwenkglenks M; Bacon P; D'Addio A; Einsele H; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vokurka S; Quinn B; McCann S;
J Clin Oncol; 2008 Mar; 26(9):1519-25. PubMed ID: 18268357
[TBL] [Abstract][Full Text] [Related]
9. Oral cryotherapy for oral mucositis management in patients receiving allogeneic hematopoietic stem cell transplantation: a prospective randomized study.
Lu Y; Zhu X; Ma Q; Wang J; Jiang P; Teng S; Zhou L; Wu D; Wang H
Support Care Cancer; 2020 Apr; 28(4):1747-1754. PubMed ID: 31302767
[TBL] [Abstract][Full Text] [Related]
10. Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group.
Gori E; Arpinati M; Bonifazi F; Errico A; Mega A; Alberani F; Sabbi V; Costazza G; Leanza S; Borrelli C; Berni M; Feraut C; Polato E; Altieri MC; Pirola E; Loddo MC; Banfi M; Barzetti L; Calza S; Brignoli C; Bandini G; De Vivo A; Bosi A; Baccarani M
Bone Marrow Transplant; 2007 Mar; 39(6):347-52. PubMed ID: 17277790
[TBL] [Abstract][Full Text] [Related]
11. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
12. Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.
Legert KG; Remberger M; Ringdén O; Heimdahl A; Dahllöf G
Support Care Cancer; 2014 Aug; 22(8):2133-40. PubMed ID: 24647488
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD.
Sugita J; Matsushita T; Kashiwazaki H; Kosugi M; Takahashi S; Wakasa K; Shiratori S; Ibata M; Shono Y; Shigematsu A; Obara M; Fujimoto K; Endo T; Nishio M; Kondo T; Hashino S; Tanaka J; Asaka M; Imamura M
Bone Marrow Transplant; 2012 Feb; 47(2):258-64. PubMed ID: 21423118
[TBL] [Abstract][Full Text] [Related]
14. Reliability and efficacy of palifermin in prevention and management of oral mucositis in patients with acute lymphoblastic leukemia: a randomized, double-blind controlled clinical trial.
Lucchese A; Matarese G; Manuelli M; Ciuffreda C; Bassani L; Isola G; Cordasco G; Gherlone E
Minerva Stomatol; 2016 Feb; 65(1):43-50. PubMed ID: 26862696
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue.
Wardley AM; Jayson GC; Swindell R; Morgenstern GR; Chang J; Bloor R; Fraser CJ; Scarffe JH
Br J Haematol; 2000 Aug; 110(2):292-9. PubMed ID: 10971384
[TBL] [Abstract][Full Text] [Related]
16. [Mucositis after allogeneic stem cell transplantation: Risk factors, clinical consequences and prophylaxis].
Bourdelin M; Daguindau E; Larosa F; Legrand F; Nerich V; Deconinck E; Limat S
Pathol Biol (Paris); 2015 Apr; 63(2):106-10. PubMed ID: 25555496
[TBL] [Abstract][Full Text] [Related]
17. Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation.
Wysocka-Słowik A; Gil L; Ślebioda Z; Kręgielczak A; Dorocka-Bobkowska B
Ann Hematol; 2021 Aug; 100(8):2079-2086. PubMed ID: 34117519
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient.
Eduardo FP; Bezinelli LM; Gobbi M; Rosin FCP; Carvalho DLC; Ferreira MH; da Silva CC; Hamerschlak N; Corrêa L
Support Care Cancer; 2019 Mar; 27(3):839-848. PubMed ID: 30109488
[TBL] [Abstract][Full Text] [Related]
19. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM
Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
[TBL] [Abstract][Full Text] [Related]
20. Variability of high-dose melphalan exposure on oral mucositis in patients undergoing prophylactic low-level laser therapy.
Rodrigues GH; Jaguar GC; Alves FA; Guollo A; Camandoni VO; Damascena AS; Lima VCC
Lasers Med Sci; 2017 Jul; 32(5):1089-1095. PubMed ID: 28512727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
